HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

motilin receptor

Also Known As:

motilin receptors; receptor, motilin

Networked: 36 relevant articles (3 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Cell Surface Receptors: 2125
      - Peptide Receptors: 1159
        Neuropeptide Receptors: 97
        motilin receptor: 36
        Gastrointestinal Hormone Receptors: 2
        motilin receptor: 36
      - Neurotransmitter Receptors: 562
        Neuropeptide Receptors: 97
        motilin receptor: 36

Experts

1.	Sanger, Gareth J: 4 articles (01/2017 - 01/2013)
2.	Takanashi, Hisanori: 4 articles (08/2009 - 03/2008)
3.	Broad, John: 3 articles (01/2017 - 01/2013)
4.	Cynshi, Osamu: 3 articles (08/2009 - 03/2008)
5.	Kamei, Kenshi: 3 articles (08/2009 - 03/2008)
6.	Muramatsu, Hiroyasu: 3 articles (08/2009 - 03/2008)
7.	Onoma, Mitsu: 3 articles (08/2009 - 03/2008)
8.	Ozaki, Ken-ichi: 3 articles (08/2009 - 03/2008)
9.	Yogo, Kenji: 3 articles (08/2009 - 03/2008)
10.	Mack, R J: 3 articles (04/2002 - 12/2000)

Related Diseases

1.	Gastroparesis 01/01/2022 - "Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis." 01/01/2016 - "In clinical trials, the motilin receptor agonist camicinal increased gastric emptying, but at lower doses reduced gastroparesis symptoms and improved appetite. " 12/01/1994 - "Erythromycin has been shown to induce premature phase 3 activity via stimulation of motilin receptors, so investigators evaluated its efficacy for the treatment of diabetic gastroparesis. " 07/01/2008 - "Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis." 09/01/1990 - "The authors mention also their experience in the treatment of severe diabetic gastroparesis with erythromycin, agonist of the gastric and duodenal motilin receptors. "
2.	Gastroesophageal Reflux (GERD) 04/01/2002 - "Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease."
3.	Dyspepsia (Indigestion) 12/01/2000 - "Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial." 12/01/2000 - "Motilin-receptor agonists are prokinetics; whether they relieve the symptoms of functional dyspepsia is unknown. " 06/05/2009 - "Since ABT-229 (a first generation of motilin receptor agonist) had failed to demonstrate symptomatic relief in functional dyspepsia and diabetic gastroparesis, there is a controversy for which of prokinetics or relaxants is clinically beneficial. "
4.	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/01/2008 - "The aim of this study was to assess the cardiovascular effect of MA-2029, a selective motilin receptor antagonist highly expected for the treatment of irritable bowel syndrome (IBS). "
5.	Critical Illness (Critically Ill) 01/01/2018 - "Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study." 01/01/2018 - "Camicinal is a novel, nonmacrolide, motilin receptor agonist that accelerates gastric emptying in critically ill patients with established feed intolerance. "

Related Drugs and Biologics

1.	N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamine
2.	Erythromycin (Erycette)
3.	MA-2029
4.	Cisapride (Propulsid)
5.	mitemcinal
6.	Motilin
7.	Ghrelin
8.	Macrolides
9.	Serotonin (5 Hydroxytryptamine)
10.	Peptides (Polypeptides)

Related Therapies and Procedures

1.	Oral Administration